Generic Companies with Tentative Approvals for: Mylan Labs

Try a free trial

See Plans and Pricing

« Back to Dashboard

Mylan Labs Generic Filers with Tentative Approvals

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or try a Free Trial
Applicant	Generic Name	NDA	Strength	Dosage Form
Mylan Labs	lamivudine; zidovudine	204914	30MG; 60MG	TABLET; ORAL SUSPENSION
Mylan Labs Ltd	emtricitabine;tenofovir disoproxil fumarate;nevirapine	206042	200MG;300MG;200MG	TABLET;ORAL
Mylan Labs Ltd	nevirapine	205921	400MG	TABLET, EXTENDED RELEASE;ORAL
Mylan Labs Ltd	abacavir;lamivudine	204311	60MG;30MG	TABLET, FOR SUSPENSION;ORAL
>Applicant	>Generic Name	>NDA	>Strength	>Dosage Form

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.